##gff-version 3
##sequence-region Q8NFJ6 1 384
Q8NFJ6	UniProtKB	Chain	1	384	.	.	.	ID=PRO_0000070083;Note=Prokineticin receptor 2	
Q8NFJ6	UniProtKB	Topological domain	1	54	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Transmembrane	55	75	.	.	.	Note=Helical%3B Name%3D1;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Topological domain	76	89	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Transmembrane	90	110	.	.	.	Note=Helical%3B Name%3D2;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Topological domain	111	136	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Transmembrane	137	157	.	.	.	Note=Helical%3B Name%3D3;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Topological domain	158	171	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Transmembrane	172	192	.	.	.	Note=Helical%3B Name%3D4;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Topological domain	193	223	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Transmembrane	224	244	.	.	.	Note=Helical%3B Name%3D5;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Topological domain	245	273	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Transmembrane	274	294	.	.	.	Note=Helical%3B Name%3D6;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Topological domain	295	313	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Transmembrane	314	334	.	.	.	Note=Helical%3B Name%3D7;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Topological domain	335	384	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Glycosylation	7	7	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Glycosylation	27	27	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NFJ6	UniProtKB	Disulfide bond	128	208	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00521	
Q8NFJ6	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_030957;Note=In HH3%3B phenotype consistent with normosmic idiopathic hypogonadotropic hypogonadism%3B decreased signaling activity. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18559922,ECO:0000269|PubMed:18826963,ECO:0000269|PubMed:25077900;Dbxref=dbSNP:rs141090506,PMID:17054399,PMID:18559922,PMID:18826963,PMID:25077900	
Q8NFJ6	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_030958;Note=In HH3%3B decreased signaling activity. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18826963,ECO:0000269|PubMed:25077900;Dbxref=dbSNP:rs74315418,PMID:17054399,PMID:18826963,PMID:25077900	
Q8NFJ6	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_072173;Note=In HH3. Y->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18559922,ECO:0000269|PubMed:28858133;Dbxref=dbSNP:rs202203360,PMID:18559922,PMID:28858133	
Q8NFJ6	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_069964;Note=In HH3%3B phenotype consistent with Kallmann syndrome. V->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18559922,ECO:0000269|PubMed:23643382;Dbxref=dbSNP:rs138672528,PMID:18559922,PMID:23643382	
Q8NFJ6	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_072978;Note=In HH3%3B phenotype consistent with Kallmann syndrome. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25077900;Dbxref=dbSNP:rs368732206,PMID:25077900	
Q8NFJ6	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_030959;Note=In HH3%3B phenotype consistent with Kallmann syndrome%3B decreased signaling activity. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18559922,ECO:0000269|PubMed:18826963;Dbxref=dbSNP:rs751875578,PMID:17054399,PMID:18559922,PMID:18826963	
Q8NFJ6	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_030960;Note=In HH3%3B phenotype consistent with Kallmann syndrome%3B decreased signaling activity. L->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18559922,ECO:0000269|PubMed:18826963,ECO:0000269|PubMed:25077900;Dbxref=dbSNP:rs74315416,PMID:17054399,PMID:18559922,PMID:18826963,PMID:25077900	
Q8NFJ6	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_030961;Note=In HH3%3B decreased signaling activity. W->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18559922,ECO:0000269|PubMed:18826963;Dbxref=dbSNP:rs201835496,PMID:17054399,PMID:18559922,PMID:18826963	
Q8NFJ6	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_072174;Note=In HH3. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18559922;Dbxref=dbSNP:rs376239580,PMID:18559922	
Q8NFJ6	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_069965;Note=In HH3%3B triallelic inheritance%3B the patient also carries mutations in GNRH1 and FGFR1. S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23643382;Dbxref=dbSNP:rs200755554,PMID:23643382	
Q8NFJ6	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_030962;Note=In HH3%3B phenotype consistent with Kallmann syndrome%3B decreased signaling activity%3B abolished ligand binding. Q->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18826963;Dbxref=dbSNP:rs74315417,PMID:17054399,PMID:18826963	
Q8NFJ6	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_072175;Note=In HH3. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18559922;Dbxref=dbSNP:rs376142095,PMID:18559922	
Q8NFJ6	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_030963;Note=In HH3%3B uncertain pathological significance%3B signaling activity is impaired. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18826963,ECO:0000269|PubMed:22927827;Dbxref=dbSNP:rs78861628,PMID:17054399,PMID:18826963,PMID:22927827	
Q8NFJ6	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_030964;Note=In HH3%3B phenotype consistent with Kallmann syndrome%3B signaling activity is impaired%3B impaired cell surface-targeting. P->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18826963,ECO:0000269|PubMed:25077900;Dbxref=dbSNP:rs149992595,PMID:17054399,PMID:18826963,PMID:25077900	
Q8NFJ6	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_030965;Note=In HH3%3B phenotype consistent with Kallmann syndrome%3B signaling activity is impaired. M->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18826963;Dbxref=dbSNP:rs74315419,PMID:17054399,PMID:18826963	
Q8NFJ6	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_030966;Note=In HH3%3B uncertain pathological significance. V->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17054399,ECO:0000269|PubMed:18559922,ECO:0000269|PubMed:18826963,ECO:0000269|Ref.3;Dbxref=dbSNP:rs117106081,PMID:17054399,PMID:18559922,PMID:18826963	
Q8NFJ6	UniProtKB	Natural variant	334	334	.	.	.	ID=VAR_072979;Note=In HH3%3B phenotype consistent with Kallmann syndrome. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25077900;Dbxref=dbSNP:rs371564610,PMID:25077900	
Q8NFJ6	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_030967;Note=T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17054399;Dbxref=dbSNP:rs755562438,PMID:17054399	
Q8NFJ6	UniProtKB	Natural variant	357	357	.	.	.	ID=VAR_072176;Note=In HH3. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18559922;Dbxref=dbSNP:rs375036628,PMID:18559922	
